The real drivers of multimillion dollar medical claims are likely to come in the innovative new treatments that are being developed right now. Understanding what is coming down the Food and Drug Administration (FDA)-approved pipeline is the first step towards being adequately prepared. With the prospect of more innovation driving high cost medical claims, insurers have options to help them prepare.
Dennis Arizin, Managing Director and John Fries, SVP, Healthcare Practice, Guy Carpenter, provide details on gene therapy, hemophilia treatments and high-cost injectables.